Taro’s Ondansetron Injection is used for the prevention of nausea and vomiting associated with chemotherapy. This new Taro sterile injectable prescription product is bioequivalent to GlaxoSmithKline’s Zofran Injection, 2mg/mL. Taro’s Ondansetron Injection will be manufactured in the company’s sterile facility in Ireland.